Table 4.
CPH (n = 13) | Placebo (n = 15) | |||||
---|---|---|---|---|---|---|
Parameter | Baseline | End of Study | p-Value | Baseline | End of Study | p-Value |
Total SCFA | 51.8 (22.4) | 55.7 (24.1) | 0.591 | 62.6 (19.5) | 62.4 (23.1) | 0.997 |
Acetic acid | 30.4 (12.3) | 32.2 (14.5) | 0.705 | 36.3 (11.9) | 35.9 (11.3) | 0.921 |
Propionic acid | 9.9 (6.3) | 10.4 (6.7) | 0.768 | 10.7 (3.8) | 10.8 (6.0) | 0.963 |
Butyric acid | 7.4 (3.9) | 8.5 (5.0) | 0.473 | 10.3 (4.5) | 10.0 (5.1) | 0.827 |
Iso-butyric acid | 1.1 (0.5) | 1.3 (0.6) | 0.257 | 1.3 (0.7) | 1.4 (0.8) | 0.595 |
Valeric acid | 1.1 (0.8) | 1.2 (0.6) | 0.785 | 1.7 (0.9) | 1.8 (1.0) | 0.805 |
Iso-valeric acid | 1.6 (0.8) | 1.9 (1.0) | 0.322 | 1.9 (1.1) | 2.0 (1.3) | 0.554 |
Caproic acid | 0.3 (0.5) | 0.3 (0.4) | 0.992 | 0.5 (0.5) | 0.6 (0.8) | 0.425 |
Iso-caproic acid | 0.0 (0,0) | 0.0 (0.0) | - | 0.01 (0.04) | 0.01 (0.04) | 0.670 |